Transmission-blocking vaccines: Uses and current status of development
- 28 February 1997
- journal article
- review article
- Published by Elsevier in International Journal for Parasitology
- Vol. 27 (2) , 183-189
- https://doi.org/10.1016/s0020-7519(96)00148-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Predicted disulfide-bonded structures for three uniquely related proteins of Plasmodium falciparum, Pfs230, Pfs4845 and Pf12Molecular and Biochemical Parasitology, 1995
- Human immune recognition of recombinant proteins representing discrete domains of the Plasmodium falciparum gamete surface protein, Pfs230Parasite Immunology, 1995
- Transmission‐blocking antibodies against multiple, non‐variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement‐fixingParasite Immunology, 1994
- Crystallization, sequence and preliminary crystallographic data for transmission-blocking anti-malaria Fab 4B7 with cyclic peptides from the Pfs25 protein of P. falciparumActa Crystallographica Section D-Biological Crystallography, 1994
- Transmission-blocking immunity against malaria and other vector-borne diseasesCurrent Opinion in Immunology, 1993
- Transmission blocking antibody of the Plasmodium falciparum zygote/ookinete surface protein Pfs25 also influences sporozoite developmentParasite Immunology, 1992
- Induction of Plasmodium falciparum Transmission-blocking Antibodies by Recombinant Vaccinia VirusScience, 1991
- Identification of a peptide sequence of the 25 kD surface protein of Plasmodium falciparum recognized by transmission‐blocking monoclonal antibodies: implications for synthetic vaccine developmentParasite Immunology, 1989
- Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum.The Journal of Experimental Medicine, 1983
- Malaria transmission blocked by immunisation with gametes of the malaria parasiteNature, 1976